Bay Street News, May 1st, 2020

Ublituximab was generally well tolerated across all cohorts including those patients receiving one-hour infusions for the 450mg dose currently being […]

HOUSTON, May 01, 2020 (GLOBE NEWSWIRE) — Houston Wire & Cable Company (Nasdaq:HWCC) will hold a conference call on Friday, […]

SASKATOON, Saskatchewan, May 01, 2020 (GLOBE NEWSWIRE) — Cameco (TSX: CCO; NYSE: CCJ) today reported its consolidated financial and operating […]

MIDDLETOWN, R.I., May 01, 2020 (GLOBE NEWSWIRE) — KVH Industries, Inc. (Nasdaq: KVHI) reported financial results for the quarter ended […]

LONDON and CARLSBAD, Calif., May 01, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the […]

CHESTERBROOK, Pa., May 01, 2020 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and […]

NEW HAMPTON, N.Y., May 01, 2020 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today for the first quarter 2020 […]

LONDON, May 01, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell […]

Study achieved primary endpoint of no drug-related serious adverse events and main secondary efficacy endpoints with 7 of the 9 […]

CARLSBAD, Calif., May 01, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on […]